跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 106 条关于
“CXCR3B”
全部
106
临床试验
55
药物
42
机构
0
资讯
9
5个月前
Edesa Biotech Prepares Phase 2 Vitiligo Trial for Mid-2026 Launch Following Promising ARDS Results
去年
Exicure Secures Australian Patent for Novel Cancer Treatment Targeting CXCR4 and GPCRx
6个月前
Pentixapharm Receives FDA Approval for CXCR4-Targeted Radiotheranostic Program in Blood Cancers
去年
Pentixapharm Pivots Clinical Strategy to Focus on CXCR4-Targeted Theranostic Oncology Platform
11个月前
Pentixapharm's CXCR4-Targeted Radiopharmaceuticals Show Promise in Primary Aldosteronism and Bladder Cancer
去年
Anti-CXCR4 and Anti-PD-1 Combination Shows Promise in Liver Cancer Treatment
3个月前
Notch2 and CXCR4 Identified as Key Drivers of Breast Cancer Dormancy in Bone Marrow
7个月前
CXCR4 Engineering Transforms CAR-T Cell Therapy: Enhanced Memory Formation and Durable Anti-Leukemic Immunity
4个月前
Pentixapharm Submits IND to FDA for Phase 3 PANDA Trial of First-in-Class CXCR4-Targeted Cardiovascular Diagnostic